Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cysticercosis.

J F Bale1

  • 1Division of Pediatric Neurology, Primary Children's Medical Center, 100 North Medical Drive, Suite 2700, Salt Lake City, UT 84113, USA. pcjbale@ihc.com

Current Treatment Options in Neurology
|November 30, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of valproic acid on organic acid metabolism in children: a metabolic profiling study.

Clinical pharmacology and therapeutics·2011
Same author

Infant botulism in the age of botulism immune globulin.

Neurology·2005
Same author

Specialty care by child neurologists: a workforce analysis.

Neurology·2005
Same author

Paroxysmal kinesigenic dyskinesia and infantile convulsions. Clinical and linkage studies. 2000.

Neurology·2002
Same author

Human cytomegalovirus a sequence and UL144 variability in strains from infected children.

Journal of medical virology·2001
Same author

Characterization of human cytomegalovirus strains by analysis of short tandem repeat polymorphisms.

Journal of clinical microbiology·2001
Same journal

Visual Impairment and Driving in Older Adults: A Narrative Review.

Current treatment options in neurology·2026
Same journal

Non-Cognitive Symptoms in Alzheimer's Disease and Their Likely Impact on Patient Outcomes. A Scoping Review.

Current treatment options in neurology·2026
Same journal

Update on the Treatment of Autonomic Disorders.

Current treatment options in neurology·2025
Same journal

Primary Progressive Aphasia Treatment: Current Treatment Options in Neurology Article Topic: Management of Primary Progressive Aphasia.

Current treatment options in neurology·2025
Same journal

Emerging Principles for Treating Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD).

Current treatment options in neurology·2025
Same journal

Diagnosis and Management of Progressive Corticobasal Syndrome.

Current treatment options in neurology·2025
See all related articles

Cysticercosis, a parasitic infection, affects millions globally. Treatment with antiparasitic drugs like albendazole can eradicate the parasite, but its role in neurocysticercosis remains debated.

Area of Science:

  • Infectious Diseases
  • Neurology
  • Parasitology

Background:

  • Cysticercosis, caused by Taenia solium, is a prevalent global parasitic infection.
  • Neurocysticercosis, a form of the disease affecting the central nervous system, is a major cause of epilepsy and hydrocephalus, particularly in developing nations.
  • Cases are increasingly seen in non-endemic regions due to immigration.

Purpose of the Study:

  • To review the current understanding and treatment strategies for cysticercosis, with a focus on neurocysticercosis.
  • To discuss the efficacy and controversies surrounding antiparasitic therapy in neurocysticercosis.
  • To outline management approaches for different forms of neurocysticercosis.

Main Methods:

  • Review of existing literature on cysticercosis and neurocysticercosis treatment.

Related Experiment Videos

  • Analysis of antiparasitic drug efficacy (albendazole, praziquantel) and adjunctive therapies (dexamethasone).
  • Description of surgical interventions for severe cases like intraventricular cysts and hydrocephalus.

    • Main Results:

    • Antiparasitic treatment can eradicate active cysticercosis infections and reduce complications.
    • The role of antiparasitic therapy in neurocysticercosis is still debated, though it's used for active parenchymal disease.
    • Concurrent dexamethasone is often necessary to manage inflammation and edema during treatment.
    • Surgical intervention is required for intraventricular cysts and hydrocephalus, while inactive lesions are managed symptomatically.

    Conclusions:

    • Antiparasitic therapy is effective for active cysticercosis but requires careful consideration in neurocysticercosis.
    • Management strategies vary based on the location and activity of the cysts.
    • Further research is needed to clarify optimal treatment protocols for neurocysticercosis.